<prompt> Answer this question truthfullyWhat medical treatment is available for leiomyosarcoma?  <response>: <reason> Uterine leiomyosarcoma LMS is the most common sarcoma arising from the uterus and comprises approximately 2 of uterine cancers. Patients diagnosed with LMS have a 5-year overall survival ranging from 25-75. The primary management of LMS is hysterectomy. Adjuvant pelvic radiotherapy has been shown to improve local control and survival of patients with leiomyosarcoma. 